Tesamorelin Peptide Explained: Visceral Fat Loss, Evidence, and Side Effects
Tesamorelin is being promoted as a peptide that can target the dangerous visceral fat surrounding your organs, but how does it actually work?Unlike traditional weight-loss drugs, Tesamorelin doesn’t directly suppress appetite or simply burn calories. It mimics Growth Hormone-Releasing Hormone, or GHRH, signaling the pituitary gland to increase the body’s own natural pulses of growth hormone. That matters because visceral fat appears particularly sensitive to growth hormone signaling.
Tesamorelin was originally developed to treat HIV-associated lipodystrophy, a condition that can cause dangerous abdominal fat accumulation in people receiving antiretroviral therapy. In 2010, the FDA approved it under the brand name Egrifta. Clinical trials found that Tesamorelin reduced visceral abdominal fat by roughly 15–20% without necessarily producing dramatic changes on the scale. Research has also explored potential effects on liver fat, metabolic health, inflammation, and even cognitive function. But manipulating the growth hormone axis comes with real trade-offs.
Side effects can include injection-site reactions, joint pain, fluid retention, numbness, changes in glucose tolerance, and increased IGF-1 levels that require monitoring. Brand-name treatment can also cost thousands of dollars per month. And once treatment stops, much of the visceral fat can return.
Tesamorelin may be one of the most clinically validated peptides available, but a smaller waistline can come with a much bigger commitment.
00:25 - How Tesamorelin Targets Visceral Fat
01:33 - The HIV Crisis That Led to Tesamorelin
02:36 - How Tesamorelin Activates Growth Hormone
05:02 - FDA Approval and the Rise of Egrifta
06:12 - What Clinical Trials Show About Visceral Fat Loss
08:59 - The Unexpected Effects on the Brain and Metabolism
11:50 - Side Effects, Glucose Risk and Cancer Concerns
14:14 - The High Cost, Gray Market and Rebound Problem
Narrated by: Josh Risser
🔔 Don't forget to SUBSCRIBE! 🔔
SUGGEST A TOPIC: https://bit.ly/suggest-an-infographics-video
💬 Come chat with me: https://discord.gg/theinfoshow
🔖 MY SOCIAL PAGES
TikTok ► https://www.tiktok.com/@theinfographicsshow
Facebook ► https://www.facebook.com/TheInfographicsShow
📝 SOURCES: https://pastebin.com/jFxesu5h
All videos are based on publicly available information unless otherwise noted. Receive SMS online on sms24.me
TubeReader video aggregator is a website that collects and organizes online videos from the YouTube source. Video aggregation is done for different purposes, and TubeReader take different approaches to achieve their purpose.
Our try to collect videos of high quality or interest for visitors to view; the collection may be made by editors or may be based on community votes.
Another method is to base the collection on those videos most viewed, either at the aggregator site or at various popular video hosting sites.
TubeReader site exists to allow users to collect their own sets of videos, for personal use as well as for browsing and viewing by others; TubeReader can develop online communities around video sharing.
Our site allow users to create a personalized video playlist, for personal use as well as for browsing and viewing by others.
@YouTubeReaderBot allows you to subscribe to Youtube channels.
By using @YouTubeReaderBot Bot you agree with YouTube Terms of Service.
Use the @YouTubeReaderBot telegram bot to be the first to be notified when new videos are released on your favorite channels.
Look for new videos or channels and share them with your friends.
You can start using our bot from this video, subscribe now to Tesamorelin Peptide Explained: Visceral Fat Loss, Evidence, and Side Effects
What is YouTube?
YouTube is a free video sharing website that makes it easy to watch online videos. You can even create and upload your own videos to share with others. Originally created in 2005, YouTube is now one of the most popular sites on the Web, with visitors watching around 6 billion hours of video every month.
